• SENSEX 75,617.88
    -677.48 (--0.89%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Tata Motors
    613.20 606.20(%)
  • Hindalco Inds.
    608.00 558.00(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Mazagon Dock
    2,542.50 995.38(%)
  • Vedanta
    403.50 297.70(%)
  • Infosys
    1,451.50 1,359.10(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Bajaj Finance
    8,795.75 9,258.95(%)
  • ICICI Bank
    1,336.40 1,372.50(%)
  • Suzlon Energy
    55.00 37.95(%)
  • Vodafone Idea
    7.85 6.60(%)
  • TCS
    3,307.55 3,396.10(%)
  • Jio Financial
    222.30 198.60(%)
  • Angel One
    2,317.80 1,942.00(%)
  • O N G C
    225.70 215.20(%)
  • Kalyan Jewellers
    485.80 337.00(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • IndusInd Bank
    675.40 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Indoco Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12579.0
  • ISIN : INE873D01024
255.57 12 (4.73%)
  • As on 04 Apr 2025 (EOD)

  • Today’s Low

    245.11

  • Today’s High

    258.44

  • Open

    246.01

  • Perv Close

    244.03

  • 52W Low

    190.00

  • 52W High

    387.55

Key Indicators

  • P/E(TTM)

    60.70

  • Mar.Cap (₹Cr.)

    2,357.58

  • Div & Yield %

    0.59

  • Book Value(₹)

    123.75

  • Debt-Equity Ratio

    4.73

  • AGM Date

    03-Apr-2025

  • EPS

    4.22

  • P/E Ratio

    60.70

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    2,357.58

  • RONW (%)

    9.07

  • ROCE (%)

    10.76

Score Board

  • Equity (₹ in Cr.)

    18.45

  • BV (₹)

    123.80

  • Sales( ₹ in Cr.)

    1,790.81

  • NP (in Cr.)

    108.15

  • NP Var(%)

    -24.0

  • Div%

    75.0

  • CPS (₹)

    21.30

  • EPS (₹)

    11.70

  • Traded Value (₹ in Lakhs)

    2,362.93

  • 52 Week High

    387.55

  • 52 Week Low

    190.00

  • Price BSE

    256.0

  • Price NSE

    256.00

  • Market Capital( in Cr.)

    2,362.93

  • P/C Ratio

    12.00

  • P/E Ratio

    21.80

  • Price Vs.BV

    11.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99 967.73
Excise Duty 1,727.10 1,577.89 1,415.96 1,146.98 1,011.84 892.72
Net Sales 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99 967.73
Other Income 8.51 2.33 2.32 3.11 2.43 6.15
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,799.32 1,669.02 1,542.04 1,243.42 1,108.42 973.89
EXPENDITURE :
Raw Materials 1,727.10 1,577.89 1,415.96 1,146.98 1,011.84 892.72
Power & Fuel Cost 1,727.10 1,577.89 1,415.96 1,146.98 1,011.84 892.72
Employee Cost 350.55 321.15 294.95 272.88 255.32 231.26
Other Manufacturing Expenses 56.66 58.79 64.15 48.29 29.95 30.58
Selling & Administrative Expenses 407.12 340.26 293.42 258.53 287.83 241.19
Miscellaneous Expenses 56.66 58.79 64.15 48.29 29.95 30.58
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,657.62 1,477.43 1,305.81 1,112.06 1,079.72 983.13
Operating Profit 172.03 140.31 103.44 82.96 79.13 67.82
Interest 36.81 25.03 14.14 22.22 26.25 20.54
Gross Profit 153.23 191.59 236.23 131.35 28.71 -9.24
Depreciation 87.98 70.60 78.95 73.12 70.81 71.56
Profit Before Tax 153.23 191.59 236.23 131.35 28.71 -9.24
Tax 32.77 55.20 93.23 38.47 3.86 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.81 -4.97 -11.52 0.48 0.60 -6.40
Reported Net Profit 116.64 141.36 154.52 92.39 24.25 -2.84
Extraordinary Items 153.23 191.59 236.23 131.35 28.71 -9.24
Adjusted Net Profit 116.64 141.36 154.52 92.39 24.25 -2.84
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 13.83 20.73 20.73 13.82 2.76 2.76
P & L Balance carried down 116.64 141.36 154.52 92.39 24.25 -2.84
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 75.00 112.50 112.50 75.00 15.00 15.00
Dividend Per Share(Rs) 1.50 2.25 2.25 1.50 0.30 0.30
Earnings Per Share-Unit Curr 12.66 15.34 16.77 10.03 2.63 -0.31
Book Value 13.83 20.73 20.73 13.82 2.76 2.76
Book Value(Adj)-Unit Curr 13.83 20.73 20.73 13.82 2.76 2.76

Shareholding Pattern

  • Promoter Group

    58.80%

  • Public Share Holding

    41.17%

  • Custodian

    0.03%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 34,214,132 37.12 34,214,132 10
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 19,986,367 21.68 19,986,367 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,200,499 58.80 54,200,499 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,152,148 1.25 1,152,148 36
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 115,287 0.13 115,287 1
Mutual Funds / UTI 16,783,598 18.21 16,783,598 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 520,959 0.57 520,959 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,571,992 20.15 18,571,992 53
2] Non Institution
Bodies Corporate 2,252,020 2.44 2,252,020 220
Clearing Members 280 0.00 280 4
Directors of their Relatives 1,136,500 1.23 1,136,500 6
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 530,570 0.58 530,570 886
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 344,926 0.37 344,926 650
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,222,014 5.66 5,096,014 23
Individuals holding nominal share capital up to Rs. 1 lakh 9,589,075 10.40 9,333,468 32,790
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 167,211 0.18 167,211 1
Sub Total 19,382,564 21.03 19,000,957 34,607
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 27,150 0.03 27,150 1
Total Shares held by Custodians and against which Depository Receipts have been issued 27,150 0.03 27,150 1
Grand Total ( A + B + C ) 92,182,205 100.00 91,800,598 34,676

Company Background

Indoco Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Indoco Remedies Ltd
  • BSE Code : 12579.0
  • ISIN : INE873D01024

  • Incorporation Year

    1947

  • Registered Office

    Indoco House 166 C S T Road
    Santacruz (East) Kalina, Mumbai,
    Maharashtra-400098

  • Telephone

    91-022-26541851-55

  • FAX

    91-022-26520787

  • Chairman

    Suresh G Kare

  • Managing Director

    Aditi Kare Panandikar

  • Company Secretary

    Ramanathan Hariharan

  • Auditor

    Gokhale & Sathe

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Indoco Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Indoco Remedies 256.15 1,799.32 1,790.81 42.91 12.31
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92